According to China Resources Pharmaceutical Group's latest financial reports the company's current revenue (TTM) is S$42.36 B. In 2022 the company made a revenue of S$42.36 B an increase over the revenue in the year 2021 that were of S$39.55 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.